A Minute With... 

Samantha Freiter, APhA–ASP Chapter President
and 2024 PharmD candidate, University of Pittsburgh
School of Pharmacy

Member since 2020

FDA issued an EUA on February 24, 2023, for the first at-home OTC diagnostic test that can differentiate and detect influenza A and B and the SARS-CoV-2 virus.

As an age-advanced (i.e., older) pharmacist, I can remember the days when proton-pump inhibitors, H2 receptor antagonists, fluticasone nasal spray, and many other self-care products required a prescription.

Kristin Wiisanen, PharmD, FAPhA, FCCP

The momentum is building for PBM reform and APhA remains focused on challenging PBM’s anticompetitive business practices which create an unequal playing field in the marketplace that disadvantages patients, pharmacists, and communities.

Ilisa BG Bernstein, PharmD, JD, FAPhA

Take the Crossword Challenge

Updates from FDA

Everyone has gas; producing and passing gas is a normal part of the digestion process.

Patients suffering from joint and muscle pain often turn to complementary and alternative medicine for relief. Arnica has a long history in treating numerous medical conditions such as insect bites, bruises, scars, fever, apprehension, sciatica, and rash, but it’s primarily recommended for inflammation, arthritis, muscle aches, and stiffness. So, what does the science say?

Mickie Cathers

In January of this year, FDA approved Brenzavvy (bexagliflozin—TheracosBio), a sodium-glucose cotransporter 2 (SGLT-2) inhibitor, as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes (T2D). Brenzavvy is the fifth SGLT-2 inhibitor to become FDA approved.

Lauren Howell, PharmD